News and Announcements

Sanofi to buy hepatitis vaccine maker Dynavax in $2.2bn deal

By Michele Maatouk

Date: Wednesday 24 Dec 2025

(Sharecast News) - France's Sanofi said on Wednesday that it has agreed to buy US hepatitis vaccine maker Dynavax in a $2.2bn deal.
Dynavax's adult hepatitis B vaccine is currently marketed in the US, while its shingles vaccine candidate is in phase 1/2 clinical development.

The company said the acquisition...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page